These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 23810678

  • 1. Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study.
    Armuzzi A, Felice C, Papa A, Marzo M, Pugliese D, Andrisani G, Federico F, De Vitis I, Rapaccini GL, Guidi L.
    J Crohns Colitis; 2013 Dec; 7(12):e623-9. PubMed ID: 23810678
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Strategies for the prevention of postoperative recurrence of Crohn's disease.
    Yamamoto T, Watanabe T.
    Colorectal Dis; 2013 Dec; 15(12):1471-80. PubMed ID: 23809911
    [Abstract] [Full Text] [Related]

  • 5. Systematic versus Endoscopy-driven Treatment with Azathioprine to Prevent Postoperative Ileal Crohn's Disease Recurrence.
    Ferrante M, Papamichael K, Duricova D, D'Haens G, Vermeire S, Archavlis E, Rutgeerts P, Bortlik M, Mantzaris G, Van Assche G, International Organization for Study of Inflammatory Bowel Diseases.
    J Crohns Colitis; 2015 Aug; 9(8):617-24. PubMed ID: 25926532
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease].
    Nos P, Hinojosa J, Aguilera V, Molés JR, Pastor M, Ponce J, Berenguer J.
    Gastroenterol Hepatol; 2000 Oct; 23(8):374-8. PubMed ID: 11227650
    [Abstract] [Full Text] [Related]

  • 8. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.
    Reinisch W, Angelberger S, Petritsch W, Shonova O, Lukas M, Bar-Meir S, Teml A, Schaeffeler E, Schwab M, Dilger K, Greinwald R, Mueller R, Stange EF, Herrlinger KR, International AZT-2 Study Group.
    Gut; 2010 Jun; 59(6):752-9. PubMed ID: 20551460
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the effectiveness of infliximab and adalimumab in preventing postoperative recurrence in patients with Crohn's disease: an open-label, pilot study.
    Tursi A, Elisei W, Picchio M, Zampaletta C, Pelecca G, Faggiani R, Brandimarte G.
    Tech Coloproctol; 2014 Nov; 18(11):1041-6. PubMed ID: 24915941
    [Abstract] [Full Text] [Related]

  • 10. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.
    Savarino E, Bodini G, Dulbecco P, Assandri L, Bruzzone L, Mazza F, Frigo AC, Fazio V, Marabotto E, Savarino V.
    Am J Gastroenterol; 2013 Nov; 108(11):1731-42. PubMed ID: 24019080
    [Abstract] [Full Text] [Related]

  • 11. Postoperative therapy with infliximab prevents long-term Crohn's disease recurrence.
    Regueiro M, Kip KE, Baidoo L, Swoger JM, Schraut W.
    Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1494-502.e1. PubMed ID: 24440221
    [Abstract] [Full Text] [Related]

  • 12. Prevention of postoperative recurrence of Crohn's disease.
    van Loo ES, Dijkstra G, Ploeg RJ, Nieuwenhuijs VB.
    J Crohns Colitis; 2012 Jul; 6(6):637-46. PubMed ID: 22398096
    [Abstract] [Full Text] [Related]

  • 13. Impact of azathioprine on the prevention of postoperative Crohn's disease recurrence: results of a prospective, observational, long-term follow-up study.
    Domènech E, Mañosa M, Bernal I, Garcia-Planella E, Cabré E, Piñol M, Lorenzo-Zúñiga V, Boix J, Gassull MA.
    Inflamm Bowel Dis; 2008 Apr; 14(4):508-13. PubMed ID: 18183602
    [Abstract] [Full Text] [Related]

  • 14. Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection.
    Regueiro M, Feagan BG, Zou B, Johanns J, Blank MA, Chevrier M, Plevy S, Popp J, Cornillie FJ, Lukas M, Danese S, Gionchetti P, Hanauer SB, Reinisch W, Sandborn WJ, Sorrentino D, Rutgeerts P, PREVENT Study Group.
    Gastroenterology; 2016 Jun; 150(7):1568-1578. PubMed ID: 26946343
    [Abstract] [Full Text] [Related]

  • 15. Direct retrospective comparison of adalimumab and infliximab in preventing early postoperative endoscopic recurrence after ileocaecal resection for crohn's disease: results from the MULTIPER database.
    Kotze PG, Yamamoto T, Danese S, Suzuki Y, Teixeira FV, de Albuquerque IC, Saad-Hossne R, de Barcelos IF, da Silva RN, da Silva Kotze LM, Olandoski M, Sacchi M, Yamada A, Takeuchi K, Spinelli A.
    J Crohns Colitis; 2015 Jul; 9(7):541-7. PubMed ID: 25820017
    [Abstract] [Full Text] [Related]

  • 16. Scheduled infliximab monotherapy to prevent recurrence of Crohn's disease following ileocolic or ileal resection: a 3-year prospective randomized open trial.
    Yoshida K, Fukunaga K, Ikeuchi H, Kamikozuru K, Hida N, Ohda Y, Yokoyama Y, Iimuro M, Takeda N, Kato K, Kikuyama R, Nagase K, Hori K, Nakamura S, Miwa H, Matsumoto T.
    Inflamm Bowel Dis; 2012 Sep; 18(9):1617-23. PubMed ID: 22081474
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD.
    Molander P, Sipponen T, Kemppainen H, Jussila A, Blomster T, Koskela R, Nissinen M, Rautiainen H, Kuisma J, Kolho KL, Färkkilä M.
    J Crohns Colitis; 2013 Oct; 7(9):730-5. PubMed ID: 23182163
    [Abstract] [Full Text] [Related]

  • 20. Interventions for prevention of post-operative recurrence of Crohn's disease.
    Doherty G, Bennett G, Patil S, Cheifetz A, Moss AC.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD006873. PubMed ID: 19821389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.